Serum lipids during treatment with glucose-insulin-potassium in myocardial infarction.
Total cholesterol, phospholipids, and triglycerides in serum were studied during myocardial infarction in a patient group treated with glucose, insulin and potassium (GIK), and a conventionally treated group. There was no difference in the typical changes of cholesterol and phospholipids between the groups, but the GIK-treated group had a late rise in triglycerides.
D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010743:Phospholipids / Q000097:blood*; D011188:Potassium / Q000627:therapeutic use*; D014280:Triglycerides / Q000032:analysis*
D007328:Insulin; D010743:Phospholipids; D014280:Triglycerides; C030396:glucose-insulin-potassium cardioplegic solution; D002784:Cholesterol; D005947:Glucose; D011188:Potassium